HomeNewsBusinessReal EstateCOVID-19 impact | Only companies with innovative ideas will survive: KP Singh

COVID-19 impact | Only companies with innovative ideas will survive: KP Singh

"The economic upheavals which are bound to unfold after the recovery from the COVID-19 episode are unimaginable at this stage. However, one thing is certain that eventually recovery will happen. When? God only knows," he said.

June 05, 2020 / 21:30 IST
Story continues below Advertisement

KP Singh, who called it a day at realty major DLF on June 4, has said that post-COVID-19, only companies with youthful energy, innovative ideas and a striving passion for quality and excellence will be able to survive.

He also expressed hope that eventually recovery will happen.

Story continues below Advertisement

"Constant change will be the name of the game," he said.

Singh, 90, joined DLF in 1961 -- a company started by his father-in-law in 1946.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show